Alumis (ALMS) News Today $5.62 +0.27 (+5.05%) Closing price 05/16/2025 04:00 PM EasternExtended Trading$5.60 -0.01 (-0.27%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock ALMS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Oppenheimer Issues Pessimistic Forecast for Alumis (NASDAQ:ALMS) Stock PriceMay 18 at 1:23 AM | americanbankingnews.comAlumis Inc. Reports Q1 2025 Financial Results and Strategic ProgressMay 16 at 12:49 AM | tipranks.comACELYRIN, Inc. Stockholders Approve Merger Agreement with Alumis Inc.May 15, 2025 | nasdaq.comACELYRIN shareholders approve Alumis merger dealMay 15, 2025 | uk.investing.comAlumis wins shareholder nod for ACELYRIN mergerMay 15, 2025 | investing.comAlumis Inc. Stockholders Approve Merger with ACELYRIN, INC.May 15, 2025 | nasdaq.comAlumis Reports First Quarter 2025 Financial Results and Highlights Recent AchievementsMay 14, 2025 | globenewswire.comHow a Peninsula biotech's merger drama overcame several investor headachesMay 13, 2025 | bizjournals.comAlumis Stockholders Approve Merger with ACELYRINMay 13, 2025 | globenewswire.comForesite Capital Management V LLC Has $45.43 Million Stake in Alumis Inc. (NASDAQ:ALMS)Foresite Capital Management V LLC raised its holdings in Alumis Inc. (NASDAQ:ALMS - Free Report) by 3.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,779,348 shares of the company's stock after buMay 12, 2025 | marketbeat.comWednesday 5/7 Insider Buying Report: ALMS, FCNCAMay 9, 2025 | nasdaq.comAlumis Inc. (NASDAQ:ALMS) Major Shareholder Acquires $86,800.00 in StockAlumis Inc. (NASDAQ:ALMS - Get Free Report) major shareholder Foresite Labs, Llc bought 20,000 shares of the stock in a transaction on Tuesday, May 6th. The stock was purchased at an average cost of $4.34 per share, with a total value of $86,800.00. Following the acquisition, the insider now owns 4,247,670 shares in the company, valued at approximately $18,434,887.80. This represents a 0.47 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Large shareholders that own 10% or more of a company's shares are required to disclose their sales and purchases with the SEC.May 9, 2025 | marketbeat.comAlumis Inc. (NASDAQ:ALMS) Major Shareholder Foresite Labs, Llc Purchases 25,000 SharesAlumis Inc. (NASDAQ:ALMS - Get Free Report) major shareholder Foresite Labs, Llc purchased 25,000 shares of the stock in a transaction on Friday, May 2nd. The stock was acquired at an average price of $4.62 per share, with a total value of $115,500.00. Following the acquisition, the insider now directly owns 4,227,670 shares in the company, valued at $19,531,835.40. This trade represents a 0.59 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Major shareholders that own 10% or more of a company's shares are required to disclose their transactions with the SEC.May 9, 2025 | marketbeat.comInsider Buying: Alumis Inc. (NASDAQ:ALMS) Major Shareholder Buys 20,000 Shares of StockMay 8, 2025 | insidertrades.comTuesday’s Top Insider Moves: Alumis Buys Surge, PennyMac Director SellsMay 7, 2025 | investing.comAlumis Inc. (NASDAQ:ALMS) Director Srinivas Akkaraju Acquires 159,920 SharesMay 7, 2025 | insidertrades.comACELYRIN Encourages Stockholders to Support Merger with Alumis Inc. Following ISS RecommendationMay 6, 2025 | quiverquant.comAlumis Inc. (NASDAQ:ALMS) Receives Average Recommendation of "Buy" from BrokeragesAlumis Inc. (NASDAQ:ALMS - Get Free Report) has been assigned a consensus recommendation of "Buy" from the nine ratings firms that are presently covering the stock, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a buy rating and two have assigned a strong buy ratinMay 6, 2025 | marketbeat.comACELYRIN urges stockholders to approve Alumis mergerMay 3, 2025 | investing.comAlumis (NASDAQ:ALMS) Given "Buy" Rating at HC WainwrightHC Wainwright restated a "buy" rating and set a $14.00 price target on shares of Alumis in a research report on Wednesday.May 2, 2025 | marketbeat.comACELYRIN, Inc. Urges Stockholders to Vote in Favor of Proposed Merger with Alumis Inc. Ahead of May 13, 2025 MeetingMay 1, 2025 | quiverquant.comForesite Capital Management VI LLC Purchases Shares of 4,202,670 Alumis Inc. (NASDAQ:ALMS)Foresite Capital Management VI LLC purchased a new stake in Alumis Inc. (NASDAQ:ALMS - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 4,202,670 shares of the company's stock, valued at approximately $33,033,000. AApril 30, 2025 | marketbeat.comAcelyrin gains as Trium Capital rebuffs M&A deal with AlumisApril 29, 2025 | msn.comHC Wainwright Weighs in on Alumis' Q1 Earnings (NASDAQ:ALMS)Alumis Inc. (NASDAQ:ALMS - Free Report) - Research analysts at HC Wainwright increased their Q1 2025 earnings per share (EPS) estimates for Alumis in a note issued to investors on Tuesday, April 22nd. HC Wainwright analyst M. Kapoor now anticipates that the company will post earnings of ($1.03) pApril 26, 2025 | marketbeat.comHC Wainwright Issues Pessimistic Forecast for Alumis (NASDAQ:ALMS) Stock PriceHC Wainwright cut their price target on shares of Alumis from $15.00 to $14.00 and set a "buy" rating for the company in a report on Tuesday.April 24, 2025 | marketbeat.comAlumis Sees Unusually Large Options Volume (NASDAQ:ALMS)Alumis Inc. (NASDAQ:ALMS - Get Free Report) was the target of unusually large options trading activity on Monday. Stock investors bought 5,003 call options on the company. This represents an increase of 147% compared to the typical daily volume of 2,026 call options.April 23, 2025 | marketbeat.comAlumis price target lowered to $14 from $15 at H.C. WainwrightApril 22, 2025 | markets.businessinsider.comAlumis and Acelyrin sign ammended merger agreementApril 21, 2025 | markets.businessinsider.comAlumis, ACELYRIN amend proposed merger pactApril 21, 2025 | msn.comACELYRIN, INC. Amends Merger Agreement with AlumisApril 21, 2025 | tipranks.comAlumis and ACELYRIN Announce Amended Merger AgreementApril 21, 2025 | globenewswire.comACELYRIN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acelyrin, Inc. - SLRNApril 16, 2025 | businesswire.comNorges Bank Acquires Shares of 204,361 Alumis Inc. (NASDAQ:ALMS)Norges Bank acquired a new position in shares of Alumis Inc. (NASDAQ:ALMS - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 204,361 shares of the company's stock, valued at approximately $1,606,000. Norges Bank owned about 0.43% of Alumis atApril 14, 2025 | marketbeat.com3 Biopharmaceutical Stocks Bucking the Sell-OffThree biopharma companies may appeal to investors looking for firms that have not been rocked by tariff-inspired turbulence.April 10, 2025 | marketbeat.comAlumis Insider Trading Activity | NASDAQ:ALMS | BenzingaApril 10, 2025 | benzinga.comAlumis: Biotech's Stock Gains >100% In A Month - But Risk Of Failure Is HighApril 8, 2025 | seekingalpha.comAlumis and ACELYRIN announce definitive merger planApril 6, 2025 | investing.comMartin Babler Buys 15,650 Shares of Alumis Inc. (NASDAQ:ALMS) StockAlumis Inc. (NASDAQ:ALMS - Get Free Report) CEO Martin Babler bought 15,650 shares of the firm's stock in a transaction that occurred on Tuesday, April 1st. The stock was purchased at an average price of $6.44 per share, with a total value of $100,786.00. Following the completion of the purchase, the chief executive officer now owns 106,454 shares in the company, valued at approximately $685,563.76. This trade represents a 17.23 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.April 5, 2025 | marketbeat.comInsider Buying: Alumis Inc. (NASDAQ:ALMS) Director Buys 16,104 Shares of StockAlumis Inc. (NASDAQ:ALMS - Get Free Report) Director Alan Colowick bought 16,104 shares of the stock in a transaction that occurred on Tuesday, April 1st. The shares were acquired at an average cost of $6.97 per share, with a total value of $112,244.88. Following the completion of the purchase, the director now owns 16,104 shares in the company, valued at $112,244.88. This represents a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.April 5, 2025 | marketbeat.comInsider Buying: Alumis Independent Director Bought US$130k Of SharesApril 5, 2025 | finance.yahoo.comAlumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed MergerApril 4, 2025 | globenewswire.comAlumis Inc. (NASDAQ:ALMS) CEO Acquires $100,786.00 in StockApril 4, 2025 | insidertrades.comAlumis (NASDAQ:ALMS) Receives "Buy" Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $15.00 price target on shares of Alumis in a research note on Wednesday.March 27, 2025 | marketbeat.comLeerink Partnrs Predicts Alumis' Q2 Earnings (NASDAQ:ALMS)Alumis Inc. (NASDAQ:ALMS - Free Report) - Investment analysts at Leerink Partnrs issued their Q2 2025 earnings estimates for shares of Alumis in a research note issued to investors on Sunday, March 23rd. Leerink Partnrs analyst T. Smith anticipates that the company will post earnings per share ofMarch 27, 2025 | marketbeat.comAlumis, Kaken Pharmaceutical enter ESK-001 collaboration and licensing agreementMarch 27, 2025 | markets.businessinsider.comAlumis Inc. Reports 2024 Results and Strategic MergerMarch 27, 2025 | tipranks.comQ1 Earnings Estimate for Alumis Issued By Leerink PartnrsAlumis Inc. (NASDAQ:ALMS - Free Report) - Analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for shares of Alumis in a research note issued on Sunday, March 23rd. Leerink Partnrs analyst T. Smith expects that the company will post earnings per share of ($1.46) for the quarter. The conMarch 26, 2025 | marketbeat.comStrategic Partnerships and Financial Projections Bolster Buy Rating for Alumis Inc.March 26, 2025 | tipranks.comAlumis stock soars on Japan dermatology dealMarch 25, 2025 | investing.comAlumis rises on licensing deal with Japan’s KakenMarch 25, 2025 | msn.com Get Alumis News Delivered to You Automatically Sign up to receive the latest news and ratings for ALMS and its competitors with MarketBeat's FREE daily newsletter. Email Address ALMS Media Mentions By Week ALMS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALMS News Sentiment▼0.050.61▲Average Medical News Sentiment ALMS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALMS Articles This Week▼124▲ALMS Articles Average Week Get Alumis News Delivered to You Automatically Sign up to receive the latest news and ratings for ALMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MLYS News SNDX News AVDL News COLL News PAHC News ELVN News PHVS News GYRE News RCUS News ARDX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALMS) was last updated on 5/19/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredBitcoin Just Broke $100K – Are You Positioned?This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alumis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alumis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALMS Stock Free ALMS Stock Alerts